Trace elements in human physiology and pathology: zinc and metallothioneins.

Zinc is one of the most abundant nutritionally essential elements in the human body. It is found in all body tissues with 85% of the whole body zinc in muscle and bone, 11% in the skin and the liver and the remaining in all the other tissues. In multicellular organisms, virtually all zinc is intracellular, 30-40% is located in the nucleus, 50% in the cytoplasm, organelles and specialized vesicles (for digestive enzymes or hormone storage) and the remainder in the cell membrane. Zinc intake ranges from 107 to 231 micromol/d depending on the source, and human zinc requirement is estimated at 15 mg/d. Zinc has been shown to be essential to the structure and function of a large number of macromolecules and for over 300 enzymic reactions. It has both catalytic and structural roles in enzymes, while in zinc finger motifs, it provides a scaffold that organizes protein sub-domains for the interaction with either DNA or other proteins. It is critical for the function of a number of metalloproteins, inducing members of oxido-reductase, hydrolase ligase, lyase family and has co-activating functions with copper in superoxide dismutase or phospholipase C. The zinc ion (Zn(++)) does not participate in redox reactions, which makes it a stable ion in a biological medium whose potential is in constant flux. Zinc ions are hydrophilic and do not cross cell membranes by passive diffusion. In general, transport has been described as having both saturable and non-saturable components, depending on the Zn(II) concentrations involved. Zinc ions exist primarily in the form of complexes with proteins and nucleic acids and participate in all aspects of intermediary metabolism, transmission and regulation of the expression of genetic information, storage, synthesis and action of peptide hormones and structural maintenance of chromatin and biomembranes.

[1]  E. Tibaduiza,et al.  Zinc transport across an endothelium includes vesicular cotransport with albumin , 1996, Journal of cellular physiology.

[2]  Milos Chuapil Effect of zinc on cells and biomembranes. , 1976 .

[3]  J. Beattie,et al.  Metallothionein and the trace minerals. , 1990, Annual review of nutrition.

[4]  R. Ravid,et al.  Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material , 1997, Journal of Neuroscience Methods.

[5]  L. Mucke,et al.  Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.

[6]  P. G. Reeves Adaptation responses in rats to long-term feeding of high-zinc diets: emphasis on intestinal metallothionein , 1995 .

[7]  J. Hesketh Zinc binding to tubulin. , 1983, The International journal of biochemistry.

[8]  Rudolph E Tanzi,et al.  Presenilins and Alzheimer's disease , 1997, Current Opinion in Neurobiology.

[9]  B. Lönnerdal Intestinal Absorption of Zinc , 1989 .

[10]  B. Vallee,et al.  The biochemical basis of zinc physiology. , 1993, Physiological reviews.

[11]  R. Palmiter,et al.  ZnT-3, a putative transporter of zinc into synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Choudhuri,et al.  Species variation in hepatic metallothionein. , 1994, Toxicology letters.

[13]  Diponkar Banerjee,et al.  IMMUNOHISTOCHEMICAL LOCALIZATION OF METALLOTHIONEIN IN CELL NUCLEUS AND CYTOPLASM OF FETAL HUMAN LIVER AND KIDNEY AND ITS CHANGES DURING DEVELOPMENT , 1987, Pathology.

[14]  Y. Masuda,et al.  Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. , 1998, Journal of biochemistry.

[15]  C. F. Mills Zinc in Human Biology , 1989, ILSI Human Nutrition Reviews.

[16]  Jie Liu,et al.  Metallothionein: an intracellular protein to protect against cadmium toxicity. , 1999, Annual review of pharmacology and toxicology.

[17]  W. Maret,et al.  The ATP-metallothionein complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Sunderman Fw The influence of zinc on apoptosis , 1995 .

[19]  J. Halsted,et al.  Zinc deficiency in man. The Shiraz experiment. , 1972, The American journal of medicine.

[20]  W. Bettger,et al.  The physiological role of zinc as an antioxidant. , 1990, Free radical biology & medicine.

[21]  G. Reynolds,et al.  Hippocampal tin, aluminum and zinc in Alzheimer's disease , 2004, Biometals.

[22]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Youn,et al.  Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. , 1996, Toxicology.

[24]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[25]  W. Maret,et al.  Control of zinc transfer between thionein, metallothionein, and zinc proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Cousins,et al.  Cysteine-rich intestinal protein and intestinal metallothionein: an inverse relationship as a conceptual model for zinc absorption in rats. , 1992, The Journal of nutrition.

[27]  W. D. Ehmann,et al.  Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.

[28]  R. Cousins,et al.  Cysteine-rich intestinal protein binds zinc during transmucosal zinc transport. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Wright,et al.  Electron transfer from cytochrome b5 to iron and copper complexes. , 1987, Biochemistry.

[30]  B. Winegar,et al.  Voltage‐dependent block by zinc of single calcium channels in mouse myotubes. , 1990, The Journal of physiology.

[31]  Y. Iiboshi,et al.  Induction of Nitric Oxide Synthase in Rat Intestine by Interleukin-1α May Explain Diarrhea Associated with Zinc Deficiency , 1997 .

[32]  D. Evans,et al.  The dihydroorotase domain of the multifunctional protein CAD. Subunit structure, zinc content, and kinetics. , 1986, The Journal of biological chemistry.

[33]  R. Lockshin,et al.  Programmed cell death. , 1974, Life sciences.

[34]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[35]  A. Van der Laarse,et al.  Isoproterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. , 1989, Journal of molecular and cellular cardiology.

[36]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[37]  W. Bettger,et al.  Zinc deficiency alters the protein composition of the membrane skeleton but not the extractability or oligomeric form of spectrin in rat erythrocyte membranes. , 1992, The Journal of nutrition.

[38]  R. Palmiter,et al.  Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[40]  A. Prasad,et al.  Biochemical studies on dwarfism, hypogonadism, and anemia. , 1963, Archives of internal medicine.

[41]  S. Samson,et al.  Molecular analyses of metallothionein gene regulation. , 1998, Progress in nucleic acid research and molecular biology.

[42]  C. Masters,et al.  A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.

[43]  D. Choi,et al.  Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-d-aspartate receptors , 1994, Neuroscience.

[44]  R. Cousins,et al.  Metal elements and gene expression. , 1994, Annual review of nutrition.

[45]  Robert M. Russell,et al.  Present Knowledge in Nutrition , 2001 .

[46]  D. Oberleas Mechanism of zinc homeostasis. , 1996, Journal of inorganic biochemistry.

[47]  R. Cousins,et al.  Tissue‐specific regulation of zinc metabolism and metallothionein genes by interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  K. P. Singh,et al.  Effect of zinc on immune functions and host resistance against infection and tumor challenge. , 1992, Immunopharmacology and immunotoxicology.

[49]  N. Fabris Immune System and Aging: Neuroimmunological Implications , 1992 .

[50]  R. Cousins Systemic Transport of Zinc , 1989 .

[51]  L. Rink,et al.  The significance of zinc for leukocyte biology , 1998, Journal of leukocyte biology.

[52]  P. Scuderi,et al.  Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. , 1990, Cellular immunology.

[53]  D. Hamer,et al.  Cell specificity and an effect of ras on human metallothionein gene expression. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Lawrence,et al.  Extracellular metallothionein effects on lymphocyte activities. , 1990, Molecular immunology.

[55]  W. Telford,et al.  Preferential induction of apoptosis in mouse CD4+CD8+αβTCRIoCD3εIo thymocytes by zinc , 1995 .

[56]  B. L. O’dell,et al.  Effect of Zinc Deficiency on Enzyme Activities in Rat and Pig Erythrocyte Membranes 1 , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[57]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. E. Hildebrand,et al.  Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.

[59]  F. Catalanotto,et al.  Zinc profiles in rheumatoid arthritis. , 1990, Clinical and experimental rheumatology.

[60]  C. Tohyama,et al.  POSSIBLE ROLE OF METALLOTHIONEIN IN THE CELLULAR DEFENSE MECHANISM AGAINST UVB IRRADIATION IN NEONATAL HUMAN SKIN FIBROBLASTS , 1994 .

[61]  R. Foster,et al.  Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. , 1990, The Journal of biological chemistry.

[62]  M. Ruz,et al.  Erythrocytes, erythrocyte membranes, neutrophils and platelets as biopsy materials for the assessment of zinc status in humans , 1992, British Journal of Nutrition.

[63]  D. Bagchi,et al.  Comparative in vitro oxygen radical scavenging ability of zinc methionine and selected zinc salts and antioxidants. , 1997, General pharmacology.

[64]  M. Panemangalore,et al.  Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. , 1983, Developmental biology.

[65]  A. Prasad Zinc in human health: An update , 1998 .

[66]  J. Haeggström,et al.  Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. , 1994, Archives of biochemistry and biophysics.

[67]  P. Casey,et al.  Identification of a Cysteine Residue Essential for Activity of Protein Farnesyltransferase , 1996, The Journal of Biological Chemistry.

[68]  G. Andrews,et al.  Regulation of metallothionein gene expression by oxidative stress and metal ions. , 2000, Biochemical pharmacology.

[69]  J. Lazo,et al.  Metallothioneins and cell death by anticancer drugs. , 1995, Annual review of pharmacology and toxicology.

[70]  M. Failla,et al.  Degradation of rat liver metallothioneins in vitro. , 1978, Biochimica et biophysica acta.

[71]  G. Lees,et al.  Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya , 1998, Brain Research.

[72]  G. Multhaup Amyloid precursor protein, copper and Alzheimer's disease. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[73]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[74]  B. L. O’dell,et al.  Physiological roles of zinc in the plasma membrane of mammalian cells , 1993 .

[75]  J. Lazo,et al.  Metallothionein null cells have increased sensitivity to anticancer drugs. , 1995, Cancer research.

[76]  H. Sandstead Zinc deficiency. A public health problem? , 1991, American journal of diseases of children.

[77]  C. Masters,et al.  The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.

[78]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[79]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[80]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[81]  Y. Lazebnik,et al.  Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Cousins Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. , 1985, Physiological reviews.

[83]  P. Zalewski,et al.  Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. , 2000, The Journal of nutrition.

[84]  R. Colvin,et al.  Evidence for a zinc/proton antiporter in rat brain , 2000, Neurochemistry International.

[85]  J. Erdman,et al.  Bioavailability of trace mineral elements. , 1983, Annual review of nutrition.

[86]  J. Koropatnick,et al.  Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. , 1995, Chemico-biological interactions.

[87]  M. Fukahori,et al.  Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in theEl (epilepsy) mouse , 1990, Brain Research.

[88]  R. Palmiter The elusive function of metallothioneins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  L. Raymond,et al.  Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. , 1997, Molecular pharmacology.

[90]  G. Kishore,et al.  Identification of the reactive cysteines of Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase and their nonessentiality for enzymatic catalysis. , 1988, The Journal of biological chemistry.

[91]  R. Tanzi,et al.  The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. , 1994, The Journal of biological chemistry.

[92]  P. Iversen,et al.  Expression and regulation of brain metallothionein , 1995, Neurochemistry International.

[93]  J. Connor,et al.  Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.

[94]  J. Constantinidis Maladie d'Alzheimer et la théorie du zinc , 1990 .

[95]  M. X. Wu,et al.  A cysteine in the C-terminal region of alanyl-tRNA synthetase is important for aminoacylation activity. , 1994, Biochemistry.

[96]  Y. Tse‐Dinh,et al.  Escherichia coli DNA topoisomerase I is a zinc metalloprotein with three repetitive zinc-binding domains. , 1988, The Journal of biological chemistry.

[97]  I. Bremner Nutritional and physiologic significance of metallothionein. , 1991, Methods in enzymology.

[98]  P. Ascher,et al.  High-Affinity Zinc Inhibition of NMDA NR1–NR2A Receptors , 1997, The Journal of Neuroscience.

[99]  G. Kerchner,et al.  Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry , 1997, The Journal of Neuroscience.

[100]  W. Maret Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc , 1995, Neurochemistry International.

[101]  E. Nielsen,et al.  Delineation of an endogenous zinc‐binding site in the human dopamine transporter , 1998, The EMBO journal.

[102]  J. King,et al.  Zinc absorption in women during pregnancy and lactation: a longitudinal study. , 1997, The American journal of clinical nutrition.

[103]  S. Powell The antioxidant properties of zinc. , 2000, The Journal of nutrition.

[104]  K. D. Collins,et al.  Dihydroorotase from Escherichia coli. Sulfhydryl group-metal ion interactions. , 1986, The Journal of biological chemistry.

[105]  B. Sarkar,et al.  In Vivo and in Vitro Iron-replaced Zinc Finger Generates Free Radicals and Causes DNA Damage (*) , 1996, The Journal of Biological Chemistry.

[106]  Y. Yamada,et al.  Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. , 1990, Archives of biochemistry and biophysics.

[107]  R. Palmiter,et al.  Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. , 1995, The EMBO journal.

[108]  T. Sugiura,et al.  Metallothionein in platelets. , 1994, International archives of allergy and immunology.

[109]  D. Butterfield,et al.  Alternations in lipid membrane fluidity and the physical state of cell-surface sialic acid in zinc-deficient rat erythrocyte ghosts. , 1987, Biochimica et biophysica acta.

[110]  K. Lawson,et al.  Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects , 1998, Current Therapeutic Research.

[111]  C. Fierke,et al.  Functional characterization of human carbonic anhydrase II variants with altered zinc binding sites. , 1994, Biochemistry.

[112]  R. Palmiter,et al.  MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Cousins,et al.  Regulation of the zinc transporter ZnT-1 by dietary zinc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. C. Godfrey,et al.  How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. , 1996, Medical hypotheses.

[115]  Aaron Klug,et al.  ‘Zinc fingers’: a novel protein motif for nucleic acid recognition , 1987 .

[116]  J. Buring,et al.  Micronutrients and HIV‐1 disease progression , 1995, AIDS.

[117]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[118]  M. Chevion,et al.  Zinc(II) protects against metal-mediated free radical induced damage: studies on single and double-strand DNA breakage. , 1991, Free radical research communications.

[119]  J. Berg,et al.  The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.

[120]  N. Abramova,et al.  Study of antioxidant properties of metal aspartates. , 1995, The Analyst.

[121]  W. H. Betts,et al.  Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). , 1993, The Biochemical journal.

[122]  C. Cho,et al.  Zinc deficiency: Its role in gastric secretion and stress-induced gastric ulceration in rats , 1987, Pharmacology Biochemistry and Behavior.

[123]  E. Shinar,et al.  Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate. , 1989, Biochimica et biophysica acta.

[124]  R. Dean,et al.  Restriction of the participation of copper in radical-generating systems by zinc. , 1991, Free radical research communications.

[125]  C. Masters,et al.  Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.

[126]  P. Dumont,et al.  Potentiation of the antitumour activity of 2-formylpyridine thiosemicarbazone by metal chelation : 2-formylpyridine thiosemicarbazone zinc sulphate (NSC 294721). , 1979, European journal of cancer.

[127]  P. E. Johnson,et al.  Homeostatic control of zinc metabolism in men: zinc excretion and balance in men fed diets low in zinc. , 1993, The American journal of clinical nutrition.

[128]  Y. Hannun,et al.  Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 , 1997, The Journal of Biological Chemistry.

[129]  P. Fraker,et al.  Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review. , 1995, Journal of the American College of Nutrition.

[130]  M. Fisman,et al.  Metals and the Liver in Alzheimer's Disease An Investigation of Hepatic Zinc, Copper, Cadmium, and Metallothionein , 1990, Journal of the American Geriatrics Society.

[131]  D. Wynford‐Thomas,et al.  IN VIVO PHOTOINDUCTION OF METALLOTHIONEIN IN HUMAN SKIN BY ULTRAVIOLET IRRADIATION , 1996, The Journal of pathology.

[132]  Y. Fukuda,et al.  Cytokines and liver disease. , 1991, Japanese journal of medicine.

[133]  J. Dórea,et al.  Zinc reverses the increased sensitivity of lymphocytes from aged subjects to the antiproliferative effect of prostaglandin E2. , 1992, Clinical immunology and immunopathology.

[134]  K. Titani,et al.  The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.

[135]  A. Wyllie,et al.  Apoptosis: an overview. , 1997, British medical bulletin.

[136]  K. Higashi,et al.  Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. , 1998, Biochemical and biophysical research communications.

[137]  K. Dakshinamurti,et al.  Neurobiology of Pyridoxine a , 1990, Advances in nutritional research.

[138]  A. Yang Abnormal sequestation of lysosomal hydrases in Aβ mediated neurotoxicity. , 1997 .

[139]  T. Houbara,et al.  Effects of zinc on production of active oxygen species by rat neutrophils. , 1995, Pharmacology & toxicology.

[140]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[141]  W. Maret,et al.  Thiolate ligands in metallothionein confer redox activity on zinc clusters. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[142]  G. Lees,et al.  Zinc and Alzheimer's disease: is there a direct link? , 1997, Brain Research Reviews.

[143]  J. King,et al.  Effect of acute zinc depletion on zinc homeostasis and plasma zinc kinetics in men. , 2001, The American journal of clinical nutrition.

[144]  J. Fisher,et al.  The Role of an α Subtype M2-M3 His in Regulating Inhibition of GABAA Receptor Current by Zinc and Other Divalent Cations , 1998, The Journal of Neuroscience.

[145]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[146]  I. Paulsen,et al.  A Novel Family of Ubiquitous Heavy Metal Ion Transport Proteins , 1997, The Journal of Membrane Biology.

[147]  K. Tsujikawa,et al.  Induction and subcellular localization of metallothionein in regenerating rat liver. , 1994, European journal of cell biology.

[148]  G. Glenner,et al.  Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease , 1988, Journal of neurochemistry.

[149]  Y. J. Kang The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[150]  D. Harrison,et al.  Apoptosis: an overview of the process and its relevance in disease. , 1997, Advances in pharmacology.

[151]  P. Hunziker,et al.  Isolation and characterization of six human hepatic isometallothioneins. , 1985, The Biochemical journal.

[152]  P. Moser-Veillon Zinc: consumption patterns and dietary recommendations. , 1990, Journal of the American Dietetic Association.

[153]  J. King,et al.  Zinc homeostasis in humans. , 2000, The Journal of nutrition.

[154]  P. Fraker,et al.  The dynamic link between the integrity of the immune system and zinc status. , 2000, The Journal of nutrition.

[155]  M Chevion,et al.  A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. , 1988, Free radical biology & medicine.

[156]  M. Jackson,et al.  Physiology of Zinc: General Aspects , 1989 .

[157]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[158]  J. Catravas,et al.  Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity. , 1998, European journal of pharmacology.

[159]  C. Cho,et al.  Effects of zinc sulphate on ethanol- and indomethacin-induced ulceration and changes in prostaglandin E2 and histamine levels in the rat gastric glandular mucosa. , 1985, Digestion.

[160]  W. D. Ehmann,et al.  Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.

[161]  K. Kröncke,et al.  Measurement of nitric oxide-mediated effects on zinc homeostasis and zinc finger transcription factors. , 1999, Methods in enzymology.

[162]  T. Smart,et al.  Modulation of GABA‐mediated synaptic transmission by endogenous zinc in the immature rat hippocampus in vitro. , 1994, The Journal of physiology.

[163]  R. Palmiter,et al.  ZnT‐2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. , 1996, The EMBO journal.

[164]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[165]  S. Traynelis,et al.  Control of Voltage-independent Zinc Inhibition of Nmda Receptors by the Nr1 Subunit , 2022 .

[166]  J. C. Smith,et al.  The role of zinc in bone metabolism. , 1974, Clinical orthopaedics and related research.

[167]  R. Palmiter,et al.  Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.

[168]  R. Colvin Characterization of a plasma membrane zinc transporter in rat brain , 1998, Neuroscience Letters.

[169]  S. M. Hadi,et al.  DNA breakage by tannic acid and Cu(II): sequence specificity of the reaction and involvement of active oxygen species. , 1994, Mutation research.

[170]  P. Hunziker,et al.  Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain , 1994, FEBS letters.

[171]  M. Gershwin,et al.  Zinc deficiency and immune function. , 1990, Annual review of nutrition.

[172]  M. Gore,et al.  Investigation of the effect of metal ions on the reactivity of thiol groups in human 5-aminolaevulinate dehydratase. , 1985, The Biochemical journal.

[173]  S. Powell Salicylate trapping of .OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. , 1994, Free radical research.

[174]  S. Srinivasula,et al.  The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.

[175]  N. Andrews,et al.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[176]  R. Palmiter,et al.  Disruption of the Metallothionein-III Gene in Mice: Analysis of Brain Zinc, Behavior, and Neuron Vulnerability to Metals, Aging, and Seizures , 1997, The Journal of Neuroscience.

[177]  C. Mitchell,et al.  Diethyldithiocarbamate and dithizone augment the toxicity of kainic acid , 1990, Brain Research.

[178]  R. Henkin,et al.  Serum and tissue zinc concentrations in patients with endoscopic esophagitis , 1992, Digestive Diseases and Sciences.

[179]  L. Morat,et al.  Zinc uptake by proximal cells isolated from rabbit kidney: Effects of cysteine and histidine , 1991, Pflügers Archiv.

[180]  R. Vandenberg,et al.  Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions. , 1998, Molecular pharmacology.

[181]  W. Maret,et al.  The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[182]  C. Jeandel,et al.  Lipid peroxidation and free radical scavengers in Alzheimer's disease. , 1989, Gerontology.